In this contest, we have previously demonstrated that in vitro exposure to the small molecule non-genotoxic activator of the p53 pathway Nutlin-3 activates the NOTCH1 pathway in B-CLL [19]. This evidence concerns the gene NOTCH1 and B-cell chronic lymphocytic leukemia.